MLT 115 Autoimmune Disorders

Focus: Preparation for next exam covering chapters 6, 7, and 8.
Recommended practice questions:
- Chapter 6: Questions 1-12.
- Chapter 7: Questions 2, 3, and 11.
- Chapter 8: Questions 2, 3, 4, 6, 7, 8, 9, 10, 13, 14, 16, 17, and 28.
- Special emphasis on questions that define key terms.
Notable omission from exam: Electrophoresis and labeling techniques tested in MLT 101.

Exam Date: Tuesday, the 17th.
Review Session: Bring questions Thursday, the 12th.
Fire Drill Warning: Expect a fire drill at 9:30 AM on exam day; possibility to start exam after drill for fewer interruptions.
Current Weather Forecast: Partly sunny, low of 30°F, high of 53°F.

Autoimmune diseases are a category of more than 80 chronic and debilitating diseases in which the body fails to recognize its own cells, leading to an immune attack on itself.
Main focus areas include:
- Common disorders:
- Lupus
- Rheumatoid arthritis
- Polycystic Ovary Syndrome (PCOS)
- Multiple Sclerosis
Autoimmune diseases can be organ-specific or affect the entire body.

Lupus: A significant autoimmune condition affecting multiple systems.
Rheumatoid Arthritis: Affects joints and can cause systemic issues such as anemia and inflammation.
Type 1 Diabetes: An autoimmune attack on insulin-producing cells in the pancreas.
Multiple Sclerosis (MS): Affects the nervous system and can be linked to exposure to certain proteins.

Autoimmunity often emerges from a failed immune response or an unusual immune activation leading to inflammation.
Triggers may include:
- Genetics: Family history can increase risk.
- Environmental Factors: Such as UV radiation, certain drugs, and viral infections (COVID-19 noted as a major trigger).
Disorders can present with symptoms of remission and relapses.

Diagnostic tests typically include ANA (Antinuclear Antibody) tests, which suggest the presence of an autoimmune disorder rather than providing definitive diagnoses.
ELISA Tests: Commonly used for autoimmune screening and identifying specific antibodies.
Rheumatoid Factor Test: Measures antibodies in rheumatoid arthritis.
Erythrocyte Sedimentation Rate (ESR): Measures inflammation; higher levels indicate active inflammatory processes.

Prevalence: Affects 1-2% of the population, especially women aged 30-50.
Symptoms:
- Swollen joints (common in hands and feet).
- Progressive inflammation resulting in deformities.
- Extra-articular symptoms affecting lungs, kidneys, and causing anemia of chronic disease.
Diagnostic Challenges:
- Presence of rheumatoid factor does not guarantee RA; false positives are common.
- Diagnostic process is often reliant on clinical symptoms rather than conclusive tests.
Current Testing Techniques: Aging increases the likelihood of false positive ANA results; new testing advances continue to improve diagnostic accuracy.

Challenges in Diagnosis: Multiple symptoms with no single definitive test; often a diagnosis of exclusion depending on patterns of symptoms and test results.
Pathology: Antibodies target nuclear components, crucial for understanding systemic lupus erythematosus (SLE).
Convention for test result interpretation: Significant attention must be paid to ANA patterns as they correlate with disease specificity.

Autoimmune conditions require vigilant diagnostic approaches; reliance on symptom patterns and comprehensive tests is essential.
Understanding the biological basis of these diseases can enhance management and treatment strategies.
Exam preparation should prioritize chapters 6, 7, and 8 content, including definitions and diagnostic tests rather than overarching historical or background issues only discussed in prior classes.

Utilize textbook references for specific autoimmune disorders and their management strategies.
Focus on understanding the implications of diagnostic test results, as they are essential for practical application in medical laboratories and clinical settings.